Popular kids' toothpastes among 4M tubes recalled nationwide
The nationwide recall affects more than 4 million tubes of toothpaste, including products featuring Barbie, Hot Wheels, Crayola and My Little Pony branding.
- 1. More than 4 million tubes of toothpaste are included in the recall, which covers more than a dozen products sold under the Brush Buddies, Evo and ARU brands.
- 2. The FDA classified the recall as Class II, citing "deviations" from current good manufacturing practice (CGMP) requirements.
- 3. A Class II recall means exposure to a product could cause "temporary or medically reversible adverse health consequences," while the likelihood of serious health consequences is considered remote, according to the FDA's website.
Article analysis
Skim this article about "Popular kids' toothpastes among 4M tubes recalled nationwide": 3 key takeaways and more.
Popular kids' toothpastes among 4M tubes recalled nationwide
skim AI Analysis | Fox Business
Fox Business on Popular kids' toothpastes among 4M tubes recalled nationwide: skim's analysis surfaces 3 key takeaways. Over 4 million tubes of children's toothpaste, including popular brands like Barbie and Hot Wheels, are being recalled nationwide due to manufacturing practice deviations. Read the takeaways in seconds, then decide whether the full article is worth your time.
Category: Lifestyle. News article analyzed by skim.
Summary
Over 4 million tubes of children's toothpaste, including popular brands like Barbie and Hot Wheels, are being recalled nationwide due to manufacturing practice deviations. The FDA classified this as a Class II recall, meaning potential health consequences are temporary and reversible.
Key Takeaways
- More than 4 million tubes of toothpaste are included in the recall, which covers more than a dozen products sold under the Brush Buddies, Evo and ARU brands.
- The FDA classified the recall as Class II, citing "deviations" from current good manufacturing practice (CGMP) requirements.
- A Class II recall means exposure to a product could cause "temporary or medically reversible adverse health consequences," while the likelihood of serious health consequences is considered remote, according to the FDA's website.
Statement Breakdown
- Claimed Facts: 70% of statements the article presents as facts
- Opinions: 10% of statements classified as editorial or subjective
- Claims: 20% of statements surfaced for additional reader evaluation
Credibility & Bias Reasoning
Credibility assessment: The article relies on information from the FDA, a credible government agency, and provides specific details about the recall. However, it also includes a disclaimer that some entities could not be reached for comment, indicating potential for incomplete information.
Bias assessment: Consumer Alert Focus. The article prioritizes informing consumers about a product recall, using a direct and alert tone. It focuses on the 'what' and 'why' of the recall from a consumer protection perspective.
Note: This article provides factual information about a product recall. Exercise caution and refer to official sources for complete details.
Credibility flag: Alerting, Factual Basis
Claimed Facts (7)
- This is a direct statement of fact about the recall and the types of products involved.
- This provides specific quantitative data about the recall, attributed to a reliable source.
- This states the official classification and the reason for the recall as provided by the FDA.
- This identifies the companies involved in the distribution and manufacturing of the recalled product.
- This provides specific product names and quantities affected by the recall.
- This details another specific set of recalled products and their quantities.
- This highlights the product with the highest number of recalled units.
Opinions (1)
- The word 'Popular' is subjective and reflects an opinion about the appeal of the toothpastes rather than a factual statement.
Claims (1)
- This statement implies an attempt to get comments that were not received, which is a factual claim about the reporting process, but the lack of comment from the involved parties could be seen as a gap in information that might lead to assumptions.
Key Sources
- U.S. Food and Drug Administration (FDA) — Government Agency
- Sophia Compton — Author
- Ashtel Studios Inc. — Distributor
- Pritam International Private Limited — Manufacturer
- FOX Business — Media Outlet
This analysis was generated by skim (skim.plus), an AI-powered content analysis platform by Credible AI. Scores and classifications represent the platform's AI-generated assessment and should be considered alongside other sources.
skim analyzes recent Fox Business coverage for what holds up, what reads as opinion, and what may not be fully supported. Last updated 22nd October 2026.